Finance

Lists
Why is AVXL down 6,44%?
Dive Deeper
AVXL:NASDAQ
Anavex Life Sciences Corp
1,89 $
-6,44%
(-0,13) 1D
1,86 $
-1,59% (-0,030)
After hours
Closed: 1 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVXL...
Open
2,00 $
High
2,01 $
Low
1,88 $
Mkt. cap
175,20 մլն
Avg. vol.
843,36 հզր
Volume
2,34 մլն
52-wk high
10,38 $
52-wk low
1,88 $
EPS
-0,15 $
Beta
1,14
Shares outstanding
92,70 մլն
No. of employees
34
Open
2,00 $
High
2,01 $
Low
1,88 $
Mkt. cap
175,20 մլն
Avg. vol.
843,36 հզր
Volume
2,34 մլն
52-wk high
10,38 $
52-wk low
1,88 $
EPS
-0,15 $
Beta
1,14
Shares outstanding
92,70 մլն
No. of employees
34
News stories
From web sources and news partners
About Anavex Life Sciences Corp
CEOChristopher U. Missling Ph.D.
Employees34
Founded2004
HeadquartersՆյու Յորք, Նյու Յորք, Միացյալ Նահանգներ
Sector-
Websiteanavex.com
Analyst
Recommendation
Action
Price target
Projected
Date
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
20,00 $
+958,2%
05/04/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
20,00 $
+958,2%
03/31/2026
Soumit Roy
JonesTrading
Hold
Maintained
-
-
11/14/2025
Last report
25 օգս, 2026 թ.
Fiscal period
Q3 2026
EPS / Est. (USD)
0,08 $ / -0,08 $
+200,00%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7,28 մլն
4,62 մլն
4,16 մլն
-4,74 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,55 մլն
2,13 մլն
2,29 մլն
-2,03 մլն
Operating expense
10,83 մլն
6,75 մլն
6,46 մլն
-6,77 մլն
Total operating expenses
10,83 մլն
6,75 մլն
6,46 մլն
-6,77 մլն
Operating income
-10,83 մլն
-6,75 մլն
-6,46 մլն
6,77 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-9,83 մլն
-5,66 մլն
-5,34 մլն
7,82 մլն
EBT excluding unusual items
-9,83 մլն
-5,66 մլն
-5,34 մլն
7,82 մլն
Income tax expense
-
18,00 հզր
-
-
Effective tax rate
-
-0,32%
-
-
Other operating expenses
-
-
-
-
Net income
-9,83 մլն
-5,68 մլն
-5,34 մլն
7,82 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,11
-0,06
-0,06
0,08
Interest and investment income
999,00 հզր
1,08 մլն
1,06 մլն
1,07 մլն
Interest expense
-
-
-
-
Net interest expenses
999,00 հզր
1,08 մլն
1,06 մլն
1,07 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps